Thomas Lennart Eklund

Thomas Lennart Eklund

Vorsitzender bei SWEDENCARE AB

Vermögen: 6 Mio $ am 31.05.2026

59 Jahre
Health Technology
Finance
Commercial Services

Profil

Mr. Thomas Lennart Eklund is an Independent Director at Surgical Science Sweden AB, an Industrial Partner at Impilo AB, a Chairman at Swedencare AB, an Independent Director at Boule Diagnostics AB, a Chairman at Circassia AB, a Chairman at Itrim Sverige AB, a Chairman at Mabtech Group Holding AB, a Chairman at Mabtech Holding AB, a Chairman at Sedana Medical AG, a Chief Executive Officer & Director at Tedsalus AB, an Investment Director at Alfred Berg ABN AMRO Capital Investment AB and a Vice President at Handelsbanken Markets Norge.
He is on the Board of Directors at Devyser Diagnostics AB, Surgical Science Sweden AB, Boule Diagnostics AB, Tedsalus AB, Bariatric & Diabetes Center Ajman AB, Bio-Works Sweden AB, Bioworks AB, Devyser AB, Excillum AB, GHP International AB, Immedica Pharma Holding AB, Impilo No 4 Holding Ii AB, Memira Holding AB, Rodebjer Form AB and Tedcap AB. Mr. Eklund was previously employed as a Chairman by Immedica Pharma AB, a Chairman by Mabtech AB, an Independent Director by Bio-Works Technologies AB, an Independent Director by SciBase Holding AB, a Chairman by Moberg Pharma AB, a Chairman by Sedana Medical AB, an Independent Director by Aerocrine AB, a Chairman by GHP Specialty Care AB, a Managing Director by Investor Growth Capital AB, a Chairman by BoMill AB, a Chairman by Bomill Holding AB, a Chief Executive Officer by Investor Growth Capital AB, a Chairman by Itrim Holding AB, a Deputy Director by Newron Sweden AB, a Deputy Director by SciBase AB, a Deputy Director by Scibase Intressenter AB, a Chairman by Swevet Holding AB, a Chairman by Swevet Piab AB, and a Chairman by Termino C 10180 AB. He received his MBA from Stockholm School of Economics.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
16.02.2026 1’009’060 ( 0.63% ) 3 Mio $ 31.05.2026
31.12.2024 1’666’464 ( 1.68% ) 2 Mio $ 31.05.2026
28.11.2025 399’170 ( 0.78% ) 2 Mio $ 31.05.2026

Aktive Positionen von Thomas Lennart Eklund

UnternehmenPositionBeginn
BOULE DIAGNOSTICS AB Direktor/Vorstandsmitglied 01.01.2014
SWEDENCARE AB Vorsitzender 01.01.2026
SURGICAL SCIENCE SWEDEN AB Direktor/Vorstandsmitglied 01.01.2017
DEVYSER DIAGNOSTICS AB Direktor/Vorstandsmitglied 01.01.2024
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Vorstandsvorsitzender -
Direktor/Vorstandsmitglied -
Vorsitzender -
░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░ ░ ░░░░░░░ ░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Thomas Lennart Eklund

UnternehmenPositionEnde
░░░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Thomas Lennart Eklund im Detail an

Ausbildung von Thomas Lennart Eklund

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

65

Beziehungen ersten Grades

58

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen58

Electronic Technology

Commercial Services

Distribution Services

Health Technology

Finance

Finance

Health Technology

Electronic Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Services

Commercial Services

Technology Services

Retail Trade

Health Services

Rodebjer Form AB

Miscellaneous

Scibase Intressenter AB

Health Technology

Sedana Medical AG

Tedcap AB

Technology Services

Health Technology

Health Technology

Consumer Services

Finance

Health Services

Health Technology

Health Technology

Scibase AB

Bomill Holding AB

Health Technology

Alfred Berg ABN AMRO Capital Investment AB

Health Technology

Swevet Piab AB

Commercial Services

Finance

Bariatric & Diabetes Center Ajman AB

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Impilo No 4 Holding Ii AB

Bioworks AB

Miscellaneous

Finance

Mabtech Group Holding AB

  1. Börse
  2. Insiders
  3. Thomas Lennart Eklund
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT